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Although the prevalence of chronic bronchitis has been measured in several populations, 
its impact on quality of life has not been assessed. We report the prevalence and impact of 
chronic bronchitis (defined as having phlegm on most days for at least 3 months during the 
previous year) among 4,708 adults ages 20 to 69 representative of the nonaged U.S. popula- 
tion. Men reported chronic bronchitis more frequently than women (12 vs 8%): smokers, 
regardless of age and sex, reported chronic bronchitis more frequently than former or never 
smokers. Among both men and women 35 years of age or older, current smokers-as op- 
posed to ex- or never smokers-with chronic bronchitis had the poorest forced expiratory 
volume in 1 set (FEV,). The most commonly reported impact of chronic bronchitis was 
worry, followed by pain and restricted activity days, regardless of age, sex, or smoking 
habits. Of those current and ex-smokers who had seen a physician about their chronic 
bronchitis, 65% of men and 44% of women had decreased or stopped smoking. Among 
those current and ex-smokers with chronic bronchitis who did not consult a physician, the 
proportion of those who had decreased or stopped smoking was 29% for men and 37% for 
women. Finally, only 43% of male current smokers and 55% of female current smokers who 
had chronic bronchitis reported that a physician had advised them to decrease or stop 
smoking. : 1986 Academic Press, Inc. 
INTRODUCTION 
Although the prevalence of chronic bronchitis has been measured in several 
populations throughout the world over the past three decades (2, 3, 9, 13), how 
this condition affects the quality of daily life has not been examined. Here we 
assess, paying special attention to smoking status, the impact of chronic bron- 
chitis as measured by pain, worry, and restricted activity days. Further, we ex- 
amine the response of individuals with and without chronic bronchitis to physi- 
cian advice to avoid or decrease smoking. 
METHODS 
This study uses data gathered during the enrollment phase of the Rand Health 
Insurance Experiment (HIE). The HIE sample represents the general nonaged 
r The work reported herein was done pursuant to the Health Insurance Experiment funded by Grant 
016B80 from the U.S. Department of Health and Human Services. The views expressed are those of 
the authors and do not necessarily reflect those of The Rand Corporation or of the Department of 
Health and Human Services. 
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population of the United States; the elderly and disabled eligible for Medicare, 
persons in the military or in various institutions, and high-income families (those 
with incomes exceeding $54,000 in 1982 dollars) were excluded. Families were 
sampled from six sites around the United States: Dayton, Ohio; Seattle, Wash- 
ington; Fitchburg/Leominster, Massachusetts; Franklin County, Massachusetts; 
Charleston, South Carolina; and Georgetown County, South Carolina. Details of 
the experimental design are described elsewhere (10). 
During enrollment, all participants completed a self-administered medical his- 
tory questionnaire that included a series of questions about emphysema, chronic 
bronchitis, and phlegm production. Those individuals not reporting a physician 
diagnosis of emphysema or chronic bronchitis or a history of phlegm production 
skipped over the remaining questions related to these conditions. The phlegm 
production questions originated from the World Health Organization/Interna- 
tional Collaborative Study of Medical Care Utilization (15). Those who did report 
presence of any of these conditions went on to complete questions about the 
impact of their conditions on daily life (described below) and about physician 
visits for their condition. A series of questions regarding smoking history and 
physician advice to avoid or decrease smoking was included in a separate ques- 
tionnaire section. All current and former smokers completed the questions on 
smoking. The validity and reliability of the questionnaire are described elsewhere 
(4, 14). 
As part of the HIE design, a 60% random sample of participants underwent a 
physical examination during enrollment. The examination included lung function 
tests consisting of three tries at a Gould M-10 spirometer to measure forced expi- 
ratory volume in 1 set (FEV,) and forced vital capacity (FVC). All measures 
were corrected for barometric temperature and pressure. The best of the three 
tries was used for analysis. We predicted each individual’s FEV, using 
Knudson’s equations (6), which take into account age, height, and sex, and then 
calculated the percentage of predicted FEV,. Knudson’s prediction equations are 
based on a sample of white individuals between 8 and 90 years of age who were 
“totally free of symptoms or history of cardiorespiratory disease and who had 
never smoked” (6). 
Definition of Chronic Bronchitis and Disease Burden 
We considered an individual to have chronic bronchitis if he or she answered 
yes to the following two questions: “During the past 12 months have you brought 
up any phlegm from your chest the first thing in the morning?” and “During the 
past year, were there at least three months when you brought up phlegm on most 
days?” This definition is similar to that recommended by the British Medical 
Research Council (1). The burden of chronic bronchitis on the individual was 
assessed by four “disease impact” questions. All persons who reported chronic 
phlegm production were asked if they had any pain, worry, restricted activity, or 
bed days related to the presence of emphysema, chronic bronchitis, or phlegm 
production. Preceded responses to the disease impact questions ranged from 
“none” to “a great deal” (worry and pain) or to “all the time” (activity restric- 
tion); these three items referred to the past 3 months. The question about days in 
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bed due to chronic bronchitis required that the respondent write either zero or the 
specific number of days spent in bed within the past 30 days. 
Data were examined using multilevel contingency tables. All reported rates, 
unless otherwise stated, were age-adjusted using the direct method, with the age 
distribution of the entire sample as a standard. 
RESULTS 
We studied 4,708 adults ages 20 to 69 years representative of the adult, nonel- 
derly U.S. population. Of those studied, 54% were women, 14% were nonwhite, 
and 38% had at least some college education. 
Prevalence of Chronic Bronchitis by Age, Sex, and Smoking Habits 
Of the study population, 10% reported the presence of phlegm on most days 
during at least 3 months during the previous year (chronic bronchitis by our defi- 
nition). Men reported chronic bronchitis more frequently than did women (12 vs 
8%); this difference was consistent across age groups (Table 1). In each age and 
sex group, current smokers reported chronic bronchitis more frequently than 
never or ex-smokers. Prevalence of chronic bronchitis rose with age among male 
current smokers, but there were no consistent age trends among other sex- and 
smoking-specific strata. 
Lung Function and Chronic Bronchitis 
The analyses in this section include the 60% random sample of participants 
from the experiment, 2,721 adults, who completed both a physical examination, 
TABLE 1 
PREVALENCE RATES (PER 100) OF CHRONIC BRONCHITIV BY SEX, AGE, AND SMOKING STATUS 









Male 20-24 134 8.2 30 13.3 150 14.0 314 11.5 
25-34 283 3.5 166 6.6 366 18.3 815 10.8 
35-44 124 10.5 133 3.8 216 18.5 473 12.3 
45-54 84 4.8 110 12.7 144 20.1 338 13.9 
55-69' 49 6.1 69 8.7 69 31.9 187 16.6 
20-69' 674 6.1 508 7.9 945 18.9 2,127 12.2 
Female 20-24 222 5.0 58 3.5 156 11.5 436 7.1 
25-34 428 4.0 126 6.4 367 14.7 921 8.6 
35-44 265 5.7 59 6.8 173 12.1 497 8.1 
45-54 206 5.3 75 6.7 165 13.9 446 8.7 
55-69' 111 4.5 49 8.2 70 17.1 230 9.1 
20-69' 1,232 4.8 367 6.3 931 13.8 2,530 8.3 
a Phlegm on most days for at least 3 months during the previous year. 
b Total number of persons in the specific age, sex, and smoking status categories. 
c Only two persons in the sample were over 62 years of age. 
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including lung function testing, and the medical history questionnaire upon enroll- 
ment in the HIE. Measures of lung function were approximately normally distrib- 
uted in each age and sex group. Both FEV, and FEV,/FVC values were higher 
than those found by the National Center for Health Statistics (NCHS) Health and 
Nutrition Examination Survey of 1971-1975 (7), but in most instances the HIE 
values fell within the 95% confidence limits for the best trial in the NCHS sur- 
vey (4). 
Percentage of predicted FEV, decreased with age regardless of bronchitis, 
smoking habits, or sex (Figs. 1 and 2). This decrease is seen for all strata, but is 
particularly marked for current smokers with and without chronic bronchitis. 
(Note that the prediction equations were based on a sample of healthy persons 
who had never smoked.) For both men and women (Figs. 1 and 2), ex-smokers 
without chronic bronchitis had the highest values for percentage of predicted 
FEV,, followed by never smokers without chronic bronchitis and current 
smokers without chronic bronchitis. Current smokers reporting chronic bron- 
chitis had the lowest measured values for percentage of predicted FEV, among 
both men and women 35 years of age or older. Ex- and never smokers with 
chronic bronchitis were excluded because of their small numbers. 
Impact Associated with Chronic Bronchitis 
As described earlier, only adults who reported emphysema, chronic bronchitis, 
or phlegm production answered a series of questions regarding the impact of 
these conditions. These analyses are limited to those individuals with chronic 
bronchitis by our definition. The presence of impact among people with chronic 
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FIG. 1. Mean percentages of predicted FEV, among men by age, cigarette smoking status, and 
presence of chronic bronchitis. 
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FIG. 2. Mean percentages of predicted FEV, among women by age, cigarette smoking status, and 
presence of chronic bronchitis. 
chronic bronchitis reported more impact than did men with chronic bronchitis. 
Never smokers with chronic bronchitis reported more impact than did either cur- 
rent or ex-smokers with chronic bronchitis; most notably, never smokers re- 
ported more restricted activity days and bed days. The most frequently reported 
impact was worry; about half of those with chronic bronchitis reported worrying 
about it. 
Effect of Physician Intervention 
Although more than half of those with chronic bronchitis reported some nega- 
tive impact from the condition during the past 3 months, less than one-third had 
TABLE 2 
AGE-ADJUSTED~ PREVALENCE RATES (PER 100) OF SELF-REPORTED IMPACT OF CHRONIC 
BRONCHITIS ON DAILY LIFE AMONG THOSE WITH CHRONIC BRONCHITIS BY SMOKING STATUS 
AND SEX 
Never smoked Ex-smoker Current smoker Total 
Male Female Male Female Male Female Male Female 
Type of impact (N = 41) (N = 59) (N = 40) (N = 23) (N = 179) (N = 127) (N = 260) (N = 209) 
Any pain during the 
past 3 months 33.3 34.5 35.7 18.8 25.3 35.5 28.1 34.1 
Any worry during the 
past 3 months 55.7 56.9 46.7 33.8 54.5 56.2 52.6 53.5 
Any restricted 
activity during the 
past 3 months 14.4 26.3 19.4 10.3 10.1 14.9 12.0 18.4 
Bed-days during the 
past 30 days 
(% with 1 or more) 8.3 5.7 5.2 4.7 1.7 4.3 3.0 4.7 
’ Adjusted for age using the direct method, all persons in the sample (both sexes) as standard 
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TABLE 3 
PERCENTAGE OF PERSONS WITH CHRONIC BRONCHITIS EVER VISITING A PHYSICIAN ABOUT THEIR 
CHRONIC BRONCHITIS ACCORDING TO SMOKING STATUS AND SEX 
Smoking status N” 
Never smoked 41 
Ex-smoker 38 














u Total number of persons in smoking status and sex-specific category. 
b Adjusted for age using the direct method, all persons in the sample (both sexes) as standard. 
ever visited a doctor about their chronic bronchitis (Table 3). Current smokers 
with chronic bronchitis received physician advice to avoid or decrease smoking 
almost twice as often as did current smokers without chronic bronchitis; never- 
theless, only 48% of current smokers with chronic bronchitis reported that their 
physician had advised them to stop smoking (Table 4). 
We expected that many smokers with chronic bronchitis would reduce their 
smoking with or without physician advice. Overall, among current and ex- 
smokers with chronic bronchitis, 35% of men and 38% of women had decreased 
or stopped smoking. Men with chronic bronchitis who had seen a physician about 
it were more than twice as likely to have decreased or stopped smoking as those 
with chronic bronchitis who had not seen a physician (Table 5). The association 
between a physician visit and a decline in smoking among women was less pro- 
nounced: Women who had seen a physician about their chronic bronchitis were 
20% more likely to have decreased or stopped smoking than those who had not. 
Impact from the condition may also influence an individual’s decision to stop 
or restrict smoking. A decrease in smoking among current and ex-smokers with 
chronic bronchitis was more common among those who reported at least some 
pain (46%), worry (42%), or activity restriction (55%) than among those without 
TABLE 4 
PERCENTAGE OF CURRENT AND Ex-SMOKERS EVER RECEIVING PHYSICIAN ADVICE TO STOP OR 
DECREASE SMOKING ACCORDING TO PRESENCE OF CHRONIC BRONCHITIS AND SEX 
Male Female 
Category NO 9P N” 72 
No chronic bronchitis 
Ex-smoker 466 14.3 343 14.3 
Current smoker 764 21.1 802 25.6 
Chronic bronchitis 
Ex-smoker 40 19.3 23 24.2 
Current smoker 179 42.6 128 54.6 
a Total number of persons in smoking status, bronchitis status, and sex-specific category. 
b Adjusted for age using the direct method, all persons in the sample (both sexes) as standard. 




Physician contact Antismoking 
about chronic advice from 
bronchitis any physician 
Male Female 
N” %b N” %b 
Ever contacted Advice 25 84.7 24 48.2 
No advice 15 37.2 13 33.1 
Total 40 65.1 37 43.5 
Never contacted Advice 60 25.6 50 44.6 
No advice 113 31.3 58 30. I 
Total 173 28.6 108 36.6 
0 Total number of persons in contact, advice, and sex-specific categories. 
b Adjusted for age using the direct method, all persons in the sample (both sexes) as standard. 
any negative impact (28%). The decrease in smoking among those with no impact 
from chronic bronchitis was about two-thirds that of those with some impact. 
DISCUSSION 
We measured the prevalence and impact of chronic bronchitis in a sample rep- 
resentative of the general, nonaged U.S. population. Because the study was 
cross-sectional, data regarding phlegm production, impact, physician advice, and 
change in smoking habits were gathered retrospectively. The validity of such in- 
formation depends on the respondent’s ability to recall accurately the desired 
event; this ability may vary with the event. Although an individual may easily 
recall a chronic condition, a doctor visit occurring as recently as 1 month earlier 
may be less accurately remembered. Finally, a person who suffered pain, worry, 
or activity restriction associated with chronic bronchitis 2 months ago may be 
less likely to report these effects than someone currently suffering from these 
impacts. Even so, more than half of those with chronic bronchitis reported some 
form of negative impact from that condition on their health. 
We found men more likely than women to comply with physician advice to 
avoid or decrease smoking, a fact consistent with the literature (11). However, 
women were more likely than men to receive, or to recall receiving, such advice. 
This may be explained by the higher rate of physician contact among women 17 
years of age or older (8). Among those with chronic bronchitis, if men usually 
wait until their condition is more severe before consulting a physician, they may 
be more likely to comply with physician advice than women, who may see a 
physician when their condition is less severe. 
Current smokers had the worst lung function and the highest rate of chronic 
bronchitis. Poor lung function and phlegm production are strong predictors of 
mortality (5, 12). Compliance with physician advice to stop smoking among pa- 
tients with pulmonary disease has been reported to be as high as 51% (11). Con- 
sidering all of these facts together, physicians should increase their efforts to offer 
antismoking advice to their patients with pulmonary symptoms. 
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